Seminars. . .

______________________________

What’s new in psychopharmacology:

Recent developments; what is on the horizon (new neurotransmitter targets: glutamate, cannabinoid receptors and oxytocin); circadian stabilization: non-medical treatments to enhance outcomes; controversies and concerns. Over the counter products. The role of non-prescribing health care professionals especially in preventing recurrence and relapses. Specific strategies for enhancing medication adherence. Treatment guide lines and ethical concerns. Finally, what pharmaceutical companies do not want you to know.